Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EXOG pseudogene 1 (EXOGP1) is a processed pseudogene related to the gene encoding exonuclease G (EXOG), a mitochondrial endo/exonuclease involved in nucleic acid metabolism and possibly programmed cell death[1]. EXOGP1 itself does not produce a functional protein product, but, consistent with many other human pseudogenes, could theoretically serve as a regulatory RNA in gene networks or act as a biomarker if expressed aberrantly in specific pathological conditions[2][3]. Pseudogenes like EXOGP1 are not considered therapeutic targets, as they lack enzymatic or receptor activity and do not interact with drugs in conventional ways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exonuclease G pseudogene 1 (EXOGP1).